Impact of age on treatment response in men with prostate cancer treated with radiotherapy

BJUI Compass ◽

10.1002/bco2.132 ◽

2021 ◽

Author(s):

Alex K. Bryant ◽

Tyler J. Nelson ◽

Rana R. McKay ◽

A. Karim Kader ◽

J. Kellogg Parsons ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Response

Download Full-text

Neuroendocrine secretory profiles are not associated with treatment response to Lu-177-PSMA-617 radioligand therapy in patients with advanced metastatic castration-resistant prostate cancer

10.1055/s-0040-1708342 ◽

2020 ◽

Author(s):

T Derlin ◽

R Werner ◽

C Henkenberens ◽

TL Ross ◽

FM Bengel

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant

Download Full-text

Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results

Journal of Basic and Clinical Health Sciences ◽

10.30621/jbachs.2019.708 ◽

2019 ◽

Author(s):

Emine Acar ◽

Burak Sönmezer ◽

Erkan Derebek ◽

Recep Bekiş ◽

Özhan Özdoğan ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Treatment ◽

Treatment Response ◽

Prostate Cancer Treatment ◽

Treatment Toxicity

Download Full-text

Faculty Opinions recommendation of Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1116473.572497 ◽

2008 ◽

Author(s):

Thomas Polascik

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Photodynamic Therapy ◽

Treatment Response ◽

Recurrent Prostate Cancer ◽

Therapy Assessment ◽

Targeted Photodynamic Therapy

Download Full-text

Identification of Genes and Genetic Variants Associated with Poor Treatment Response in Patients with Prostate Cancer

10.21236/ada614000 ◽

2014 ◽

Author(s):

Lisa A. Cannon-Albright ◽

Neeraj Agarwal ◽

Craig Teerlink

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Genetic Variants ◽

Poor Treatment ◽

Poor Treatment Response

Download Full-text

Early PSA Kinetics for Low- and Intermediate-Risk Prostate Cancer with Favorable Treatment Response Treated with HDR Brachytherapy, SBRT, Hfrt, and Cfrt

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.313 ◽

2018 ◽

Vol 102 (3) ◽

pp. e115-e116

Author(s):

C.C. Hansen ◽

M.A. Hallman ◽

K. Ruth ◽

J. Gou ◽

J.J. Paly ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Intermediate Risk ◽

Hdr Brachytherapy ◽

Psa Kinetics ◽

Risk Prostate Cancer

Download Full-text

Prospective comparative study of 18F-sodium fluoride PET/CT and planar bone scintigraphy for treatment response assessment of bone metastases in patients with prostate cancer

Acta Oncologica ◽

10.1080/0284186x.2018.1438651 ◽

2018 ◽

Vol 57 (8) ◽

pp. 1063-1069 ◽

Author(s):

Randi Fuglsang Fonager ◽

Helle Damgaard Zacho ◽

Niels Christian Langkilde ◽

Joan Fledelius ◽

June Anita Ejlersen ◽

...

Keyword(s):

Prostate Cancer ◽

Comparative Study ◽

Bone Metastases ◽

Treatment Response ◽

Bone Scintigraphy ◽

Sodium Fluoride ◽

Response Assessment ◽

Pet Ct ◽

Prospective Comparative Study ◽

Treatment Response Assessment

Download Full-text

Results of a Prospective Phase 2 Pilot Trial of 177Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2018.09.014 ◽

2019 ◽

Vol 17 (1) ◽

pp. 15-22 ◽

Author(s):

Louise Emmett ◽

Megan Crumbaker ◽

Bao Ho ◽

Kathy Willowson ◽

Peter Eu ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Pilot Trial ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Prospective Phase

Download Full-text

Adding carboplatin to chemotherapy regimens for metastatic castrate‐resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes

The Prostate ◽

10.1002/pros.24048 ◽

2020 ◽

Vol 80 (14) ◽

pp. 1216-1222

Author(s):

Mohamed E. Ahmed ◽

Jack R. Andrews ◽

Jamal Alamiri ◽

Julianna Higa ◽

Rimki Haloi ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Treatment Response ◽

Survival Outcomes ◽

Castrate Resistant Prostate Cancer ◽

Impact On Treatment ◽

Castrate Resistant

Download Full-text

222P Tolerability and treatment response to darolutamide (DARO) in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in the phase III ARAMIS trial

Annals of Oncology ◽

10.1016/j.annonc.2020.10.442 ◽

2020 ◽

Vol 31 ◽

pp. S1327-S1328

Author(s):

M.R. Smith ◽

N.D. Shore ◽

T.L.J. Tammela ◽

M-A. Le Berre ◽

O. Petrenciuc ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Phase Iii ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-17-2745 ◽

2018 ◽

Vol 24 (16) ◽

pp. 3908-3916 ◽

Author(s):

R. Jeffrey Karnes ◽

Vidit Sharma ◽

Voleak Choeurng ◽

Hussam Al-Deen Ashab ◽

Nicholas Erho ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Treatment Response ◽

Genomic Signature ◽

Development And Validation

Download Full-text